Effect of Highly Active Antiretroviral Therapy on Tacrolimus Pharmacokinetics in Hepatitis C Virus and HIV Co-Infected Liver Transplant Recipients in the ANRS HC-08 Study
- 1 January 2007
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 46 (11) , 941-952
- https://doi.org/10.2165/00003088-200746110-00002
Abstract
To characterise the interactions between tacrolimus and antiretroviral drug combinations in hepatitis C virus-HIV co-infected patients who had received a liver transplant.Keywords
This publication has 45 references indexed in Scilit:
- CYP3A4 and P-Glycoprotein Activity in Healthy Controls and Transplant Patients on Cyclosporin vs. Tacrolimus vs. SirolimusAmerican Journal of Transplantation, 2004
- Treatment for Adult HIV InfectionJAMA, 2004
- Pharmacokinetic Enhancement of Protease Inhibitor TherapyClinical Pharmacokinetics, 2004
- Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patientsLiver Transplantation, 2003
- Therapeutic drug monitoring of immunosuppressive drugs in kidney transplantationCurrent Opinion in Nephrology and Hypertension, 2002
- Mechanisms of Clinically Relevant Drug Interactions Associated with TacrolimusClinical Pharmacokinetics, 2002
- Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase InhibitorsClinical Pharmacokinetics, 2001
- Pharmacokinetics and Potential Interactions Amongst Antiretroviral Agents Used To Treat Patients with HIV InfectionClinical Pharmacokinetics, 1999
- TacrolimusDrugs, 1997
- Clinical Pharmacokinetics of TacrolimusClinical Pharmacokinetics, 1995